Avenue Therapeutics ATXI

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.01 (-1.00%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Avenue Therapeutics (ATXI)
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $0.98

  • Market Cap

    $2.01 Million

  • Price-Earnings Ratio

    0.01

  • Total Outstanding Shares

    2.05 Million Shares

  • Total Employees

    3

  • Dividend

    No dividend

  • IPO Date

    June 27, 2017

  • SIC Description

    Pharmaceutical Preparations

  • Primary Exchange

    NASDAQ

  • Type

    Common Stock

  • Headquarters

    1111 kane concourse, Bay harbor islands, FL, 33154

  • Homepage

    https://www.avenuetx.com

Historical Stock Splits

If you bought 1,125 shares of ATXI before September 23, 2022, you'd have 1 share today.
Execution DateSplit Amount
April 26, 20241-for-75 (Reverse Split)
September 23, 20221-for-15 (Reverse Split)

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow, Continuing$1.62 Million
Net Cash Flow From Financing Activities$13.02 Million
Net Cash Flow From Operating Activities, Continuing$-10.59 Million
Net Cash Flow From Operating Activities$-10.59 Million
Net Cash Flow From Investing Activities$-814,000
Net Cash Flow$1.62 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Basic Earnings Per Share$90.82
Income/Loss From Continuing Operations Before Tax$-9.52 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$8.81 Million
Research and Development$7.06 Million
Net Income/Loss$-9.52 Million
Operating Income/Loss$-11.81 Million

Comprehensive Income

October 1, 2023 to September 30, 2024
MetricValue
Comprehensive Income/Loss Attributable To Parent$-9.52 Million
Other Comprehensive Income/Loss$0
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Comprehensive Income/Loss$-9.52 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Equity Attributable To Noncontrolling Interest$-958,000
Noncurrent Assets$0
Current Liabilities$973,000
Equity$1.65 Million
Assets$2.63 Million
Equity Attributable To Parent$2.61 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about ATXI from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    â“’ 2025 Financhle. All Rights Reserved.